Preparation of Dräger Atlan A350 and General Electric Healthcare Carestation 650 anesthesia workstations for malignant hyperthermia susceptible patients

Zur Kurzanzeige

dc.identifier.uri http://dx.doi.org/10.15488/16566
dc.identifier.uri https://www.repo.uni-hannover.de/handle/123456789/16693
dc.contributor.author Heiderich, Sebastian
dc.contributor.author Thoben, Christian
dc.contributor.author Dennhardt, Nils
dc.contributor.author Krauß, Terence
dc.contributor.author Sümpelmann, Robert
dc.contributor.author Zimmermann, Stefan
dc.contributor.author Reitz, Michael
dc.contributor.author Rüffert, Henrik
dc.date.accessioned 2024-03-15T08:58:02Z
dc.date.available 2024-03-15T08:58:02Z
dc.date.issued 2021
dc.identifier.citation Heiderich, S.; Thoben, C.; Dennhardt, N.; Krauß, T.; Sümpelmann, R. et al.: Preparation of Dräger Atlan A350 and General Electric Healthcare Carestation 650 anesthesia workstations for malignant hyperthermia susceptible patients. In: BMC Anesthesiology 21 (2021), Nr. 1, 315. DOI: https://doi.org/10.1186/s12871-021-01533-0
dc.description.abstract Background: Patients at risk of malignant hyperthermia need trigger-free anesthesia. Therefore, anesthesia machines prepared for safe use in predisposed patients should be free of volatile anesthetics. The washout time depends on the composition of rubber and plastic in the anesthesia machine. Therefore, new anesthesia machines should be evaluated regarding the safe preparation for trigger-free anesthesia. This study investigates wash out procedures of volatile anesthetics for two new anesthetic workstations: Dräger Atlan A350 and General Electric Healthcare (GE) Carestation 650 and compare it with preparation using activated charcoal filters (ACF). Methods: A Dräger Atlan and a Carestation 650 were contaminated with 4% sevoflurane for 90 min. The machines were decontaminated with method (M1): using ACF, method 2 (M2): a wash out method that included exchange of internal parts, breathing circuits and soda lime canister followed by ventilating a test lung using a preliminary protocol provided by Dräger or method 3 (M3): a universal wash out instruction of GE, method 4 (M4): M3 plus exchange of breathing system and bellows. Decontamination was followed by a simulated trigger-free ventilation. All experiments were repeated with 8% desflurane contaminated machines. Volatile anesthetics were detected with a closed gas loop high-resolution ion mobility spectrometer with gas chromatographic pre-separation attached to the bacterial filter of the breathing circuits. Primary outcome was time until < 5 ppm of volatile anesthetics and total preparation time. Results: Time to < 5 ppm for the Atlan was 17 min (desflurane) and 50 min (sevoflurane), wash out continued for a total of 60 min according to protocol resulting in a total preparation time of 96-122 min. The Carestation needed 66 min (desflurane) and 24 min (sevoflurane) which could be abbreviated to 24 min (desflurane) if breathing system and bellows were changed. Total preparation time was 30-73 min. When using active charcoal filters time to < 5 ppm was 0 min for both machines, and total preparation time < 5 min. Conclusion: Both wash out protocols resulted in a significant reduction of trace gas concentrations. However, due to the complexity of the protocols and prolonged total preparation time, feasibility in clinical practice remains questionable. Especially when time is limited preparation of the anesthetic machines using ACF remain superior. eng
dc.language.iso eng
dc.publisher [Erscheinungsort nicht ermittelbar] : BioMed Central
dc.relation.ispartofseries BMC Anesthesiology 21 (2021), Nr. 1
dc.rights CC BY 4.0 Unported
dc.rights.uri https://creativecommons.org/licenses/by/4.0
dc.subject Malignant hyperthermia eng
dc.subject Patient safety eng
dc.subject Succinylcholine eng
dc.subject Trigger-free anesthesia eng
dc.subject Volatile anesthetics eng
dc.subject.ddc 610 | Medizin, Gesundheit
dc.title Preparation of Dräger Atlan A350 and General Electric Healthcare Carestation 650 anesthesia workstations for malignant hyperthermia susceptible patients eng
dc.type Article
dc.type Text
dc.relation.essn 1471-2253
dc.relation.doi https://doi.org/10.1186/s12871-021-01533-0
dc.bibliographicCitation.issue 1
dc.bibliographicCitation.volume 21
dc.bibliographicCitation.firstPage 315
dc.description.version publishedVersion eng
tib.accessRights frei zug�nglich
dc.bibliographicCitation.articleNumber 315


Die Publikation erscheint in Sammlung(en):

Zur Kurzanzeige

 

Suche im Repositorium


Durchblättern

Mein Nutzer/innenkonto

Nutzungsstatistiken